Board of the Pension Protection Fund Has $644,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Board of the Pension Protection Fund trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 35.0% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,300 shares of the medical equipment provider's stock after selling 700 shares during the period. Board of the Pension Protection Fund's holdings in Intuitive Surgical were worth $644,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Atala Financial Inc acquired a new position in Intuitive Surgical during the fourth quarter worth $25,000. Parvin Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $26,000. Global Financial Private Client LLC raised its stake in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock valued at $26,000 after acquiring an additional 38 shares in the last quarter. Hurley Capital LLC acquired a new stake in Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Summit Securities Group LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $30,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Price Performance

Shares of ISRG traded down $0.48 during trading hours on Friday, hitting $533.71. The stock had a trading volume of 2,014,026 shares, compared to its average volume of 1,673,711. The stock has a market capitalization of $191.29 billion, a price-to-earnings ratio of 78.26, a P/E/G ratio of 5.53 and a beta of 1.67. The company's fifty day moving average is $531.06 and its two-hundred day moving average is $536.83. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same period in the prior year, the firm earned $1.50 earnings per share. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Gary Loeb sold 1,700 shares of the firm's stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now owns 2,245 shares of the company's stock, valued at $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 4,998 shares of company stock worth $2,611,577. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on ISRG shares. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and cut their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Piper Sandler decreased their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Evercore ISI dropped their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Finally, Royal Bank Of Canada decreased their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.